Ignite Creation Date:
2025-12-24 @ 12:00 PM
Ignite Modification Date:
2025-12-29 @ 9:16 AM
Study NCT ID:
NCT06090461
Status:
COMPLETED
Last Update Posted:
2025-06-25
First Post:
2023-10-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Real-World Evidence on the Cardiovascular Safety of CONTRAVE® in the United States (U.S.)
Sponsor:
Currax Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12
Completion Date Type:
ACTUAL
First Submit Date:
2023-10-12
First Submit QC Date:
None
Study First Post Date:
2023-10-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-04-04
Results First Submit QC Date:
None
Results First Post Date:
2025-06-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-16
Last Update Post Date:
2025-06-25
Last Update Post Date Type:
ACTUAL